EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 40 / No 10 (Octobre 2024) Med Sci (Paris), 40 10 (2024) 729-736 References
Open Access
Issue
Med Sci (Paris)
Volume 40, Number 10, Octobre 2024
Page(s) 729 - 736
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2024115
Published online 25 October 2024
  1. Mahmood SS, Levy D, Vasan RS, et al. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet 2014 ; 383 : 999–1008. [CrossRef] [PubMed] [Google Scholar]
  2. Newson L. Menopause and cardiovascular disease. Post Reprod Health 2018 ; 24 : 44–9. [CrossRef] [PubMed] [Google Scholar]
  3. Muka T, Oliver-Williams C, Kunutsor S, et al. Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis. JAMA Cardiol 2016 ; 1 : 767–76. [CrossRef] [PubMed] [Google Scholar]
  4. Davezac M, Buscato M, Zahreddine R, et al. Estrogen Receptor and Vascular Aging. Front Aging 2021 ; 2 : 727380. [CrossRef] [PubMed] [Google Scholar]
  5. Anesi N, Miquel C-H, Laffont S, et al. The Influence of Sex Hormones and X Chromosome in Immune Responses. Curr Top Microbiol Immunol 2023 ; 441 : 21–59. [PubMed] [Google Scholar]
  6. Tramunt B, Smati S, Grandgeorge N, et al. Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia 2020 ; 63 : 453–61. [CrossRef] [PubMed] [Google Scholar]
  7. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses’ health study. N Engl J Med 1991 ; 325 : 756–62. [CrossRef] [PubMed] [Google Scholar]
  8. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 2002 ; 288 : 321–33. [CrossRef] [PubMed] [Google Scholar]
  9. Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007 ; 297 : 1465–1477. [CrossRef] [PubMed] [Google Scholar]
  10. Hodis HN, Mack WJ, Henderson VW, et al. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol. N Engl J Med 2016 ; 374 : 1221–31. [CrossRef] [PubMed] [Google Scholar]
  11. Ellis S, Franks DW, Nielsen MLK, et al. The evolution of menopause in toothed whales. Nature 2024 ; 627 : 579–85. [CrossRef] [PubMed] [Google Scholar]
  12. Gilmer G, Hettinger ZR, Tuakli-Wosornu Y, et al. Female aging: when translational models don’t translate. Nat Aging 2023 ; 3 : 1500–8. [CrossRef] [PubMed] [Google Scholar]
  13. Hayashi T, Fukuto JM, Ignarro LJ, et al. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci USA 1992 ; 89 : 11259–63. [CrossRef] [PubMed] [Google Scholar]
  14. Gisclard V, Miller VM, Vanhoutte PM. Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 1988 ; 244 : 19–22. [PubMed] [Google Scholar]
  15. Wynne FL, Payne JA, Cain AE, et al. Age-Related Reduction in Estrogen Receptor-Mediated Mechanisms of Vascular Relaxation in Female Spontaneously Hypertensive Rats. Hypertension 2004 ; 43 : 405–12. [CrossRef] [PubMed] [Google Scholar]
  16. Nicholson CJ, Sweeney M, Robson SC, et al. Estrogenic vascular effects are diminished by chronological aging. Sci Rep 2017 ; 7 : 12153. [CrossRef] [PubMed] [Google Scholar]
  17. Guivarc’h E, Favre J, Guihot A-L, et al. Nuclear Activation Function 2 Estrogen Receptor α Attenuates Arterial and Renal Alterations Due to Aging and Hypertension in Female Mice. J Am Heart Assoc 2020 ; 9 : e013895. [CrossRef] [PubMed] [Google Scholar]
  18. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990 ; 81 : 1680–7. [CrossRef] [PubMed] [Google Scholar]
  19. Elhage R, Bayard F, Richard V, et al. Prevention of fatty streak formation of 17beta-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice. Circulation 1997 ; 96 : 3048–52. [CrossRef] [PubMed] [Google Scholar]
  20. Haarbo J, Leth-Espensen P, Stender S, et al. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest 1991 ; 87 : 1274–9. [CrossRef] [PubMed] [Google Scholar]
  21. Clarkson TB, Meléndez GC, Appt SE. Timing hypothesis for postmenopausal hormone therapy: its origin, current status, and future. Menopause 2013 ; 20 : 342–53. [CrossRef] [PubMed] [Google Scholar]
  22. Mikkola TS, Clarkson TB. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res 2002 ; 53 : 605–19. [CrossRef] [PubMed] [Google Scholar]
  23. Cann JA, Register TC, Adams MR, et al. Timing of Estrogen Replacement Influences Atherosclerosis Progression and Plaque Leukocyte Populations in ApoE−/− Mice. Atherosclerosis 2008 ; 201 : 43. [CrossRef] [PubMed] [Google Scholar]
  24. Krasinski K, Spyridopoulos I, Asahara T, et al. Estradiol Accelerates Functional Endothelial Recovery After Arterial Injury. Circulation 1997 ; 95 : 1768–72. [CrossRef] [PubMed] [Google Scholar]
  25. Brouchet L, Krust A, Dupont S, et al. Estradiol Accelerates Reendothelialization in Mouse Carotid Artery Through Estrogen Receptor-α but Not Estrogen Receptor-β. Circulation 2001 ; 103 : 423–8. [CrossRef] [PubMed] [Google Scholar]
  26. Zahreddine R, Davezac M, Smirnova N, et al. Tamoxifen Accelerates Endothelial Healing by Targeting ERα in Smooth Muscle Cells. Circ Res 2020 ; 127 : 1473–87. [CrossRef] [PubMed] [Google Scholar]
  27. Gennaro G, Ménard C, Michaud S-E, et al. Age-dependent impairment of reendothelialization after arterial injury: role of vascular endothelial growth factor. Circulation 2003 ; 107 : 230–3. [CrossRef] [PubMed] [Google Scholar]
  28. Arnal J-F, Lenfant F, Metivier R, et al. Membrane and Nuclear Estrogen Receptor Alpha Actions: From Tissue Specificity to Medical Implications. Physiol Rev 2017 ; 97 : 1045–87. [CrossRef] [PubMed] [Google Scholar]
  29. Barton M, Filardo EJ, Lolait SJ, et al. Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives. J Steroid Biochem Mol Biol 2018 ; 176 : 4–15. [CrossRef] [PubMed] [Google Scholar]
  30. Kalluri AS, Vellarikkal SK, Edelman ER, et al. Single-Cell Analysis of the Normal Mouse Aorta Reveals Functionally Distinct Endothelial Cell Populations. Circulation 2019 ; 140 : 147–63. [CrossRef] [PubMed] [Google Scholar]
  31. Arnal J-F, Fontaine C, Billon-Galés A, et al. Estrogen Receptors and Endothelium. Arterioscler Thromb Vasc Biol 2010 ; 30 : 1506–12. [CrossRef] [PubMed] [Google Scholar]
  32. Billon-Galés A, Fontaine C, Douin-Echinard V, et al. Endothelial Estrogen Receptor-α Plays a Crucial Role in the Atheroprotective Action of 17β-Estradiol in Low-Density Lipoprotein Receptor-Deficient Mice. Circulation 2009 ; 120 : 2567–76. [CrossRef] [PubMed] [Google Scholar]
  33. Toutain CE, Filipe C, Billon A, et al. Estrogen receptor alpha expression in both endothelium and hematopoietic cells is required for the accelerative effect of estradiol on reendothelialization. Arterioscler Thromb Vasc Biol 2009 ; 29 : 1543–50. [CrossRef] [PubMed] [Google Scholar]
  34. Tarhouni K, Guihot AL, Freidja ML, et al. Key role of estrogens and endothelial estrogen receptor α in blood flow-mediated remodeling of resistance arteries. Arterioscler Thromb Vasc Biol 2013 ; 33 : 605–11. [CrossRef] [PubMed] [Google Scholar]
  35. Smirnova NF, Fontaine C, Buscato M, et al. The Activation Function-1 of Estrogen Receptor Alpha Prevents Arterial Neointima Development Through a Direct Effect on Smooth Muscle Cells. Circ Res 2015 ; 117 : 770–778. [CrossRef] [PubMed] [Google Scholar]
  36. Zimmerman MA, Budish RA, Kashyap S, et al. GPER-novel membrane oestrogen receptor. Clin Sci (Lond) 2016 ; 130 : 1005–16. [CrossRef] [PubMed] [Google Scholar]
  37. Peixoto P, Aires RD, Lemos VS, et al. GPER agonist dilates mesenteric arteries via PI3K-Akt-eNOS and potassium channels in both sexes. Life Sci 2017 ; 183 : 21–7. [CrossRef] [PubMed] [Google Scholar]
  38. Novensà L, Novella S, Medina P, et al. Aging Negatively Affects Estrogens-Mediated Effects on Nitric Oxide Bioavailability by Shifting ERα/ERβ Balance in Female Mice. PLoS One 2011 ; 6 : e25335. [CrossRef] [PubMed] [Google Scholar]
  39. Losordo DW, Kearney M, Kim EA, et al. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994 ; 89 : 1501–10. [CrossRef] [PubMed] [Google Scholar]
  40. Jones MJ, Goodman SJ, Kobor MS. DNA methylation and healthy human aging. Aging Cell 2015 ; 14 : 924–32. [CrossRef] [PubMed] [Google Scholar]
  41. Gardini ES, Chen GG, Fiacco S, et al. Differential ESR1 Promoter Methylation in the Peripheral Blood—Findings from the Women 40+ Healthy Aging Study. Int J Mol Sci 2020 ; 21 : 3654. [CrossRef] [PubMed] [Google Scholar]
  42. Gavin KM, Seals DR, Silver AE, et al. Vascular Endothelial Estrogen Receptor α Is Modulated by Estrogen Status and Related to Endothelial Function and Endothelial Nitric Oxide Synthase in Healthy Women. J Clin Endocrinol Metab 2009 ; 94 : 3513–20. [CrossRef] [PubMed] [Google Scholar]
  43. Tarhouni K, Guihot A-L, Vessières E, et al. Determinants of flow-mediated outward remodeling in female rodents: respective roles of age, estrogens, and timing. Arterioscler Thromb Vasc Biol 2014 ; 34 : 1281–9. [CrossRef] [PubMed] [Google Scholar]
  44. Adlanmerini M, Solinhac R, Abot A, et al. Mutation of the palmitoylation site of estrogen receptor α in vivo reveals tissue-specific roles for membrane versus nuclear actions. Proc Natl Acad Sci U S A 2014 ; 111 : E283–90. [CrossRef] [PubMed] [Google Scholar]
  45. Davezac M, Zahreddine R, Buscato M, et al. The different natural estrogens promote endothelial healing through distinct cell targets. JCI Insight 2023 ; 8 : e161284. [CrossRef] [PubMed] [Google Scholar]
  46. Fischer GM, Swain ML. Effects of estradiol and progesterone on the increased synthesis of collagen in atherosclerotic rabbit aortas. Atherosclerosis 1985 ; 54 : 177–85. [CrossRef] [PubMed] [Google Scholar]
  47. Haarbo J, Hansen BF, Christiansen C. Hormone replacement therapy prevents coronary artery disease in ovariectomized cholesterol-fed rabbits. APMIS 1991 ; 99 : 721–7. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.